Greg Russotti

Greg Russotti is the Chief Technology Officer at Century Therapeutics. Before joining Century, Greg was Vice President of Cell Therapy Development and Operations at Celgene. During his tenure there, he guided CMC efforts for five different cell therapy products to IND and clinical stage development. Greg was also a leader in establishing in-house clinical manufacturing at Celgene, and in building Celgene’s first commercial CAR T manufacturing facility. Prior to Celgene, Greg held various leadership roles at Merck Research Laboratories, developing vaccines and monoclonal antibodies for clinical and commercial manufacturing. Greg received his BS and MS degrees in Chemical Engineering from Rensselaer Polytechnic Institute and his PhD in Chemical and Biochemical Engineering from Rutgers University. He has held a visiting professorship in Rutgers Biomedical Engineering department since 2008. Greg also serves as Industrial Executive Board Chairman of the Marcus Center for the Commercialization of Cell Therapies at Georgia Tech, and as an Executive Committee member of the NSF-funded Center for the Manufacturing of Advanced Therapeutics at Georgia Tech.